Fundamental dimension Equity attribute | BYRNLeader $4.82▼-0.41% Cap $112.8MP/E -12.7x QuantScore60/100 | AIROPeer $4.75▼-0.63% Cap $149.9MP/E -5.7x QuantScore49/100 | CYRXPeer $17.98▲+0.84% Cap $910.7MP/E -21.9x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
77/100 |
23/100 |
95/100 |
Valuation Multiples, PEG & DCF upside | 47/100 | 33/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 83/100 | 45/100 | 34/100 |
Growth Revenue / earnings growth & margins | 53/100 | 73/100 | 38/100 |
Sentiment Analyst ratings, targets & revisions | 40/100 | 70/100 | 59/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -12.7x | -5.7x | -21.9x |
Forward P/E (next FY) | -7.7x | -4.0x | -22.8x |
EV / EBITDA (TTM) | -12.8x | -32.0x | -279.1x |
Price / Sales | 1.2x | 1.4x | 4.9x |
Price / Free Cash Flow | 18.1x | -2.6x | -44.8x |
PEG ratio | 0.14 | 0.02 | 0.14 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 3 / 9 | 3 / 9 |
Altman Z-Score | 7.54 (Safe) | 2.18 (Grey) | 1.25 (Distress) |
Total debt / equity | 0.02 | 0.01 | 0.47 |
Quick ratio | 1.9x | 2.3x | 2.0x |
Interest coverage | — | -29.4x | -18.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +37.7% | +4.6% | -24.5% |
Net income growth YoY | -24.3% | +89.4% | +178.6% |
Gross margin (TTM) | 54.6% | 58.7% | 47.1% |
Operating margin (FY) | 10.0% | -31.6% | -20.9% |
FCF margin (FY) | -7.8% | -39.1% | -15.9% |
5. Trailing price performancePrice change over period |
1M return | +33.1% | -34.1% | +3.3% |
3M return | +36.2% | -30.1% | +17.0% |
6M return | -21.6% | -40.1% | +69.8% |
Year to date | -71.3% | -41.9% | +87.3% |
1Y return | -77.0% | -72.8% | +67.1% |
3Y return | +15.6% | -80.2% | +65.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-21.94 -555.1% premium | $-19.07 -501.4% premium | $-10.79 -160.0% premium |
Wall Street consensus target | $4.00 -17.0% · range $3.50–$4.50 | $11.00 +131.6% · range $11.00–$11.00 | $20.19 +12.3% · range $13.50–$26.00 |
Consensus stance | 71% Buy29% Hold0% Sell | 67% Buy33% Hold0% Sell | 79% Buy21% Hold0% Sell |